$83.38 - Intraday high as of 1:43 PM
$83.35 - January 27 high
$83.20 - January 25 high
$83.16 - January 22 high
$81.98 - Current price/Monday close
$81.63 - Intraday low as of 1:43 PM
$81.00 - Monday low
Eli Lilly and Company (NYSE: LLY) disclosed that the FDA has approved an expanded indication for Synjardy® (empagliflozin and metformin hydrochloride) tablets to include treatment-naïve adults with type 2 diabetes (T2D). According to the...
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) and Boehringer Ingelheim
announced a new collaboration on a Phase 1b study that will evaluate the safety
and tolerability of abemaciclib (LY2835219), Lilly's cyclin-dependent kinase
(CDK) 4 and...